image description

MagVenture has been selling transcranial magnetic stimulation devices and TMS coils since 1992. We strive to offer TMS professionals the best TMS equipment in the market.

1992:  First MagPro stimulator hits the market (sold under the Dantec brand).

image description
The first MagPro stimulator from 1992

2001: MagVenture introduces the cost-effective Static Cool concept, allowing TMS researchers to run protocols without changing coils in the middle of sessions.

MagVenture takes coil cooling to a new level with the Dynamic Cool concept, allowing TMS researchers to perform consecutive rTMS treatments without coil change.

MagVenture is officially established under its own name.

2010: Subsidiary MagVenture Inc. is established in the US.

2010: MagVenture launches a complete rTMS research system, including a coil for double-blinded placebo-trials.

2011: MagVenture is the first TMS provider to receive CE approval for its depression treatment system known as MagVita TMS Therapy, now named MagVenture TMS Therapy.

Subsidiary MagVenture GmbH is established in Germany.

2013: Researchers can now perform rTMS inside an MRi scanner with the new Mri-B91 coil from MagVenture.The Cool B91 coil is for so-called interleaved TMS in an MRi Tesla scanner. 
b91 mri coil magventure

A new coil for stimulating rodents sees the light of day, providing a valuable tool for animal model research.

 The MagPro R20 is released, a taylormade solution for smaller start-up practices.

MagVenture receives FDA clearance for the treatment of major depressive disorder. 

Sales Subsidiary MagVenture Ltd., located in Reading just outside London, is established in the UK.

2018:  MagVenture receives FDA clearance for a  3 minute TBS depression treatment. This TBS (Theta burst stimulation) protocol is based on the world’s largest Randomized Control Trial with TMS to date. The article was published in the Lancet[Blumberger et al, 2018, The Lancet].  

2018: Besides subsidiaries in the US, Germany and the United Kingdom, MagVenture is now also represented in 50+ countries. MagVenture also launches a new, dark blue logo: 

logoer magventure

2019: MagVenture receives CE approval  for a  3 minute TBS depression treatment.

2019: Sales Subsidiary MagVenture Ltda., located in São Paulo, is established in Brazil:

 MV brazil linkedin

2020: MagVenture receives FDA clearance for adjunct treatment of Obsessive-Compulsive Disorder (OCD) in adult patients. 

2021: MagVenture takes coil positioning to a whole new level with the introduction of the MagVenture Flow Arm

2021: MagVenture receives CE approval for Addiction and OCD in adult patients

  • Addiction, more specifically treatment of Psychoactive Substance User Disorder (PSUD) in adult patients.
  • OCD: Adjunct treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD)
  • Furthermore,  MagVenture TMS Therapy® can reduce the symptoms of comorbid anxiety in patients suffering from depression

News & Events

Sign up for newsletter

Get the latest news about MagVenture and TMS directly in your inbox.

contact us

Talk to an expert

Do you need help? Let us know how our experts can help you.

Subscribe to the MagVenture Newsletter

By clicking on the submit button, I confirm that I have read and agree to MagVenture’s Terms of Use.